## Abstract Our study examined the __in vitro__ and __in vivo__ responses of a newly discovered HGF/SF antagonist, NK4, on HGF/SFβpromoted growth of human prostate cancer cells (PCβ3). Nude mice were s.c. injected with either PCβ3β and/or HGF/SFβproducing fibroblasts (MRC5), and tumor size was meas
NK4 (HGF-antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
β Scribed by Kunio Matsumoto; Toshikazu Nakamura
- Book ID
- 108582266
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 1010 KB
- Volume
- 94
- Category
- Article
- ISSN
- 1347-9032
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatocyte Growth Factor/Scatter Factor (HGF/SF) is a heterodimeric molecule that plays a key role in the regulation of migration, invasion and angiogenesis in cancer, via activation of its receptor, c-met. HGF/SF is composed of an alpha-chain, containing the N-terminal hairpin domain and 4 kringle
## Abstract NK4 exhibits two distinct biological actions: antagonistic inhibition of hepatocyte growth factor (HGF) through binding to the Met/HGF receptor, and antiangiogenic action through binding to perlecan. Here, the antiβtumor effect of NK4 on malignant pleural mesothelioma was investigated.